0
Clinicopathologic Reports, Case Reports, and Small Case Series |

Tadalafil Associated With Anterior Ischemic Optic Neuropathy FREE

George K. Escaravage Jr, MD; John D. Wright Jr, MD; Syndee J. Givre, MD, PhD
[+] Author Affiliations

Section Editor: W. Richard Green, MD

More Author Information
Arch Ophthalmol. 2005;123(3):399-400. doi:10.1001/archopht.123.3.399.
Text Size: A A A
Published online

Tadalafil (Cialis; Eli Lilly, Indianapolis, Ind) is used to treat erectile dysfunction.1 Sildenafil (Viagra; Pfizer, New York, NY), a similar medication, has been associated with nonarteritic anterior ischemic optic neuropathy (NAAION).2,3 We describe a patient who developed NAAION after he took tadalafil.

A 59-year-old man with prostate cancer and erectile dysfunction underwent uncomplicated laparoscopic prostatectomy. His only other medical problem was depression, treated with buproprion hydrochloride. The immediate postoperative hematocrit measured 25.2%. The patient was ambulating and hemodynamically stable on postoperative day 1 and that evening took 20 mg of tadalafil. Fifteen hours later, he reported dizziness lasting several minutes. Blood pressure and pulse measured 126/61 mm Hg and 99 bpm, respectively. The episode resolved spontaneously. Forty-five hours after ingesting tadalafil, he noted sudden, persistent “graying” in the inferior visual field of the left eye. The next day, he took 20 mg of tadalafil. The graying did not change.

Examination 6 days later revealed acuity of 20/20 OU, with a left relative afferent pupillary defect. Perimetry (Swedish Interactive Threshold Algorithm Standard 24-2) was normal in the right eye and showed inferior altitudinal loss in the left eye (Figure 1). The fundi were normal except for 2 cotton-wool spots in the macula right eye, left optic disc edema, and nerve fiber layer hemorrhage (Figure 2). The right optic disc was crowded. The remainder of the examination results were normal. Hematocrit measured 30.2%. Erythrocyte sedimentation rate and C-reactive protein levels were normal. He had no symptoms of temporal arteritis. Six weeks later, acuities and fields were unchanged in each eye, the left optic disc edema was resolving, and no cotton-wool spots were seen.

Place holder to copy figure label and caption
Figure 1.

Swedish Interactive Threshold Algorithm Standard 24-2 pattern deviation plot of the left eye. There is inferior altitudinal visual field loss.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Left optic disc. There is edema and a superior nerve fiber layer hemorrhage.

Graphic Jump Location

Nonarteritic anterior ischemic optic neuropathy developed 45 hours after taking tadalafil. Tadalafil, a phosphodiesterase type 5 inhibitor, enhances erection through smooth muscle relaxation and increased blood flow in the corpus cavernosum. Forty-five hours is within 2.5 half-lives for a drug that is effective for at least 36 hours, the latest time point tested in clinical trials.1 In this case, crowded optic discs and postoperative anemia were concurrent risk factors for NAAION.4 However, the patient was mobile and asymptomatic prior to taking tadalafil.

Pomeranz et al3 published a case series of NAAION associated with sildenafil, another phosphodiesterase type 5 inhibitor. Sildenafil lowers systemic blood pressure, which could contribute to NAAION. The authors proposed that sildenafil might also contribute to NAAION by vasodilation of the optic disc circulation and interference with vascular autoregulation. Tadalafil acts similarly but is more specific for phosphodiesterase type 5 (found in the corpus cavernosum) and has a longer half-life; also, tadalafil did not lower systemic blood pressure in clinical trials.1 Nonarteritic anterior ischemic optic neuropathy associated with tadalafil would more likely be due to a local effect on optic disc circulation.

Pomeranz et al3 suggested that patients with a history of unilateral NAAION not use sildenafil. No definite association between tadalafil and NAAION can be made on the basis of the current case. Similarly, the cotton-wool spots might have been related to anemia, tadalafil, or both. However, this case should heighten awareness among ophthalmologists and physicians prescribing tadalafil, especially postoperatively. Further experience with tadalafil will provide data on the validity of an association with NAAION.

Correspondence: Dr Givre, Department of Ophthalmology, University of North Carolina at Chapel Hill, 5100 Bioinformatics, CB#7040, Chapel Hill, NC 27599-7040 (givre@med.unc.edu).

Financial Disclosure: None.

 Cialis [package insert].  Indianapolis, Ind Eli Lilly & Co2003;
Egan  RPomeranz  H Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 2000;118291- 292
PubMed
Pomeranz  HDSmith  KHHart  WM  JrEgan  RA Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002;109584- 587
PubMed
Kelman  SE Ischemic optic neuropathies. Miller  NRNewman  NJWalsh & Hoyt’s Clinical Neuro-Ophthalmology 5th Edition Philadelphia, Pa Lippincott Williams & Wilkins1998;549- 571

Figures

Place holder to copy figure label and caption
Figure 1.

Swedish Interactive Threshold Algorithm Standard 24-2 pattern deviation plot of the left eye. There is inferior altitudinal visual field loss.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Left optic disc. There is edema and a superior nerve fiber layer hemorrhage.

Graphic Jump Location

Tables

References

 Cialis [package insert].  Indianapolis, Ind Eli Lilly & Co2003;
Egan  RPomeranz  H Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 2000;118291- 292
PubMed
Pomeranz  HDSmith  KHHart  WM  JrEgan  RA Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002;109584- 587
PubMed
Kelman  SE Ischemic optic neuropathies. Miller  NRNewman  NJWalsh & Hoyt’s Clinical Neuro-Ophthalmology 5th Edition Philadelphia, Pa Lippincott Williams & Wilkins1998;549- 571

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles